DjinTonic said...
BBinSC said...
UPDATE:
Visit w RO today. Ordered a Decipher genetic test and a Bone Scan
Will develop a plan for RT when those results are back.
Also drew blood to check Testosterone level and a PSA test (last results in September).
Stay tuned....
The very first validation study for the Decipher test for intermediate Gleason Group Grades, (3+4) and (4+3), was just published in an ASCO meeting abstract (lead author Daniel Spratt, one of the leading research radiologists specializing in PCa). This is very good news, and confirms Decipher validation beyond the previously validated group of high-risk men (G8-10).
Validation of the performance of the Decipher biopsy genomic classifier in intermediate-risk prostate cancer on the phase III randomized trial NRG Oncology/RTOG 0126. (2022)
"Conclusions: This study represents the first validation of any biopsy-based gene expression classifier in intermediate-risk prostate cancer. Decipher is independently prognostic and can identify patients that have low rates of metastatic events despite not receiving concurrent hormone therapy, and can be used to help personalize therapy in this setting. Clinical trial information: NCT00033631."
Perhaps this will change the current recommendation, which is, I believe, that ADT accompany RT for (4+3) but not (3+4).
DjinGood info, thanks for sharing.
-B